MyAverix Finance
SHG · Healthcare
Jiangsu Aidea Pharmaceutical Co Ltd (688488)
Biotechnology
Jiangsu Aidea Pharmaceutical Co Ltd (688488) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $6.74B, P/E ratio is 18.00, net margin is -2.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688488
Jiangsu Aidea Pharmaceutical Co Ltd (688488) — FAQ
What is Jiangsu Aidea Pharmaceutical Co Ltd's market cap?
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a reported market cap of $6.74B (data as of 2026-03-29).
What is 688488's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Aidea Pharmaceutical Co Ltd (688488) is 18.00 (data as of 2026-03-29).
Does Jiangsu Aidea Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Aidea Pharmaceutical Co Ltd (688488). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Aidea Pharmaceutical Co Ltd in?
Jiangsu Aidea Pharmaceutical Co Ltd (688488) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688488 listed on?
688488 is listed on SHG.
What is Jiangsu Aidea Pharmaceutical Co Ltd's net margin?
Jiangsu Aidea Pharmaceutical Co Ltd (688488) reports a net margin of -2.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.